Company intelligence / Profile preview

Hanwha Impact

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Hanwha Impact is NOT primarily a biotech/life science company; it is an investment arm focusing chiefly on eco-friendly energy, sustainability, and disruptive innovations, including some investments in biotechnology and life sciences companies (such as Tessera Therapeutics and Inari Agriculture)[1][2][9]. It does not develop drugs or devices itself, but invests in multiple sectors.

Industry: Investors

Partnerships

Inari AgricultureTessera TherapeuticsCatalog Technologies

Beyond the preview

Go deeper on Hanwha Impact.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hanwha Impact.

Explore the full profile